Fri, Oct 31st, 2008 | Archive |

WASHINGTON – The government should ban the diabetes drug Avandia because of a wide variety of life-threatening risks, including heart and liver damage, a consumer group said Thursday.The consumer group, Public Citizen, filed a petition with the Food and Drug ...Read More

Where's the Beef? 10 Unexpectedly Risky Foods

Tue, Oct 6th, 2009 | Most Viewed |

Where's the Beef? 10 Unexpectedly Risky Foods High-profile cases of illness due to contaminated beef, such as the 1993 Jack in the Box hamburger outbreaks that killed four children, may be one reason why meat is often framed as the primary culprit of food poisoning. While the Centers ...Read More

FDA sees no safety issues with Pfizer HIV drug

Tue, Oct 6th, 2009 | Top Stories |

WASHINGTON—The Food and Drug Administration said Tuesday an HIV drug from Pfizer appears safe for expanded use in patients who have not already taken other drugs to combat the virus. Selzentry is currently approved as a secondary option for HIV patients ...Read More

FDA says Pfizer's pill Selzentry appears safe for broader use against HIV

Tue, Oct 6th, 2009 | Top Stories |

WASHINGTON (AP) - The Food and Drug Administration said Tuesday an HIV drug from Pfizer appears safe for expanded use in patients who have not already taken other drugs to combat the virus. Selzentry is currently approved as a secondary option ...Read More

FDA panel unanimously backs Glaxo cancer drug

Mon, Oct 5th, 2009 | Top Stories |

GAITHERSBURG, Md. -- Federal health advisers say an experimental kidney cancer drug from GlaxoSmithKline can benefit patients by slowing the disease, despite some risk of liver damage. The Food and Drug Administration's cancer drug panel voted unanimously in favor of Glaxo's ...Read More

US swine flu vaccination gets underway

Mon, Oct 5th, 2009 | Top Stories |

* More than 1.3 million doses ordered so far * Officials not sure how many will line up for vaccine * Surveys suggest more than half will seek vaccine WASHINGTON, Oct 5 (Reuters) - Healthcare workers in Indiana and Tennessee began getting the ...Read More

Depomed says shingles pain drug meets study goal

Mon, Oct 5th, 2009 | Business |

MENLO PARK, Calif.—Depomed Inc. on Monday reported a successful late stage clinical trial of a drug intended to treat pain following the viral infection shingles, and its shares soared on the news. The company said its DM-1796 significantly reduced post-shingles pain ...Read More

Amercan Express president leaving company

Mon, Oct 5th, 2009 | Business |

NEW YORK — American Express Co. said Monday its president, Alfred F. Kelly Jr., will step down early next year. Kelly, 51, wants to run a company as a chief executive, a position that is unlikely to come open anytime soon ...Read More

Allergan Suing Government Over off-Label Policy

Fri, Oct 2nd, 2009 | Top Stories |

Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech. The company contends in a lawsuit filed Thursday that it should be ...Read More

Botox maker suing FDA over off-label policy

Fri, Oct 2nd, 2009 | Top Stories |

NEW YORK - Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech. The company contends in a lawsuit filed Thursday that ...Read More

FDA questions safety of Glaxo kidney cancer drug

Thu, Oct 1st, 2009 | Top Stories |

Federal regulators say an experimental kidney cancer drug from GlaxoStmithKline appears to cause liver problems, potentially outweighing its ability to slow the disease. London-based Glaxo wants the Food and Drug Administration to approve the drug for advanced kidney cancer, a rare ...Read More

Vaccine unlikely to blame in girl's death, official says

Wed, Sep 30th, 2009 | Top Stories |

LONDON—The death of 14-year-old girl was very unlikely to have been caused by the vaccine she was givenhours before she died, a British health official said yesterday. Natalie Morton died in a hospital Monday only hours after being the given ...Read More

Glaxo's Cervarix vaccine faces delays, concerns

Tue, Sep 29th, 2009 | Most Viewed |

* FDA needs more time to weigh product * No indication delay is linked to UK death * Vaccine batch recalled following teenager's death * Cervarix gets support in Japan WASHINGTON, Sept 29 (Reuters) - GlaxoSmithKline Plc's(GSK.L) (GSK.N) bid to sell its Cervarix cervical ...Read More

FDA delays Glaxo cervical cancer vaccine ruling

Tue, Sep 29th, 2009 | Top Stories |

WASHINGTON - The Food and Drug Administration has delayed a decision on GlaxoSmithKline's vaccine for cervical cancer, according to the British drugmaker. The FDA was scheduled to announce its ruling Tuesday on whether to approve Cervarix, but a Glaxo spokeswoman said ...Read More

Tylenol recalls some children's medications

Fri, Sep 25th, 2009 | Business |

The makers of Tylenol have recalled almost two dozen types of children's and infant's medications as a precaution against possible contamination. The liquid products were being voluntarily pulled from stores and warehouses because bacteria were detected in one of the ...Read More

Allos says FDA clears lymphoma drug Folotyn

Fri, Sep 25th, 2009 | Business |

WESTMINSTER, Colo. -- Allos Therapeutics Inc. said Friday that regulators approved its injectable drug Folotyn as a treatment for peripheral T-cell lymphoma, a group of rare, agressive blood cancers, sending its shares soaring. Allos said the Food and Drug Administration granted ...Read More

Wyeth denied order to block rival's generic drug

Thu, Sep 24th, 2009 | Business |

TRENTON, N.J.—A federal judge on Thursday rejected drugmaker Wyeth's request for a temporary restraining order to block a rival from selling a generic version of a lucrative Wyeth antibiotic. The move comes after Wyeth sued the Food and Drug Administration Wednesday. Wyeth ...Read More

Wyeth sues FDA to block generic rival of antibiotic Zosyn

Thu, Sep 24th, 2009 | Business |

TRENTON, N.J. - Drug maker Wyeth yesterday sued the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could harm critically ill patients. Madison, ...Read More

Wyeth sues FDA to block rival generic antibiotic

Wed, Sep 23rd, 2009 | Business, Top Stories |

TRENTON, N.J. — Drugmaker Wyeth on Wednesday sued the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could harm critically ill patients. Madison, ...Read More

FDA Warns on Circumventing Flavored-Cigarette Ban

Tue, Sep 22nd, 2009 | Most Viewed, Top Stories, U.S. |

Food and Drug Administration officials warned companies Tuesday to think twice about circumventing a new ban on certain flavored cigarettes by introducing similar products like little cigars. Specifically, the ban affects cigarettes with fruit, candy or clove flavors. Although such products ...Read More

FDA says tamper-proof OxyContin provides 'limited' benefit over original painkiller

Tue, Sep 22nd, 2009 | Top Stories |

WASHINGTON - Federal health officials say a new version of the painkiller OxyContin that is designed to be harder to abuse offers some improvements over the original pill. Purdue Pharma LP has touted the new pill's plastic-like coating, which is designed ...Read More